Keefe Bruyette analyst Meyer Shields lowered the firm’s price target on Marsh McLennan (MMC) to $210 from $214 and keeps an Underperform rating on the shares. The firm expects decelerating property and casualty rate increases to pressure sentiment on insurance brokers.